COCHISE
Phase 2 Terminated
18 enrolled 9 charts
Lithium
Phase 1 Terminated
2 enrolled
Standard Therapy With or Without Surgery and Mitomycin C in Treating Patients With Advanced Limited Peritoneal Dissemination of Colon Cancer
Phase 3 Terminated
340 enrolled
QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine
Phase 1/2 Terminated
2 enrolled 13 charts
HIGH-LIGHT
Phase 2 Terminated
21 enrolled 12 charts
A Study of Amifostine (Ethyol) in Patients With Colorectal Cancer
Phase 2 Terminated
4 enrolled 9 charts
SENTINEL
Phase 1 Terminated
10 enrolled 13 charts
Combination of Cetuximab, Capecitabine, and Oxaliplatin With or Without Bevacizumab
Phase 2 Terminated
23 enrolled 8 charts
Standard of Care Alone or in Combination With Ad-CEA Vaccine and Avelumab in People With Previously Untreated Metastatic Colorectal Cancer QUILT-2.004
Phase 2 Terminated
30 enrolled 15 charts
Study of Bevacizumab Combined With Capecitabine and Either Oxaliplatin or Irinotecan as First Course of Treatment for Patients With Colorectal Cancer That Has Spread Beyond the Colon
Phase 2 Terminated
7 enrolled 5 charts
IPOX-FOLFIRI
Phase 1 Terminated
1 enrolled
Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer
Phase NA Terminated
3 enrolled 8 charts
5-FU Based Maintenance Therapy in RAS Wild Type Metastatic Colorectal Cancer After Induction With FOLFOX Plus Panitumumab
Phase 3 Terminated
4 enrolled
MRI in Predicting Response in Patients Receiving Combination Chemotherapy and Bevacizumab For Advanced or Metastatic Colorectal Cancer
Phase 2 Terminated
5 enrolled
McCAVE
Phase 2 Terminated
197 enrolled 24 charts
Radiation Therapy, Chemotherapy, and Cetuximab Followed by Surgery, Chemotherapy, and Cetuximab in Treating Patients With Locally Advanced or Metastatic Rectal Cancer That Can Be Removed by Surgery
Phase 2 Terminated
19 enrolled
BEVATOMOX
Phase 2 Terminated
83 enrolled
SHR-1210 in Combination With BP102 and XELOX in Patient With Metastatic Colorectal Cancer
Phase 2 Terminated
12 enrolled
FOLFIRI or FOLFOX With or Without Cetuximab in Patients With Metastatic Adenocarcinoma of the Colon or Rectum
Phase 3 Terminated
238 enrolled
A Study of Xeloda (Capecitabine) in Combination With Avastin + Short Course Chemotherapy in Patients With Metastatic Colorectal Cancer
Phase 2 Terminated
41 enrolled 6 charts
Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer
Phase 3 Terminated
32 enrolled 14 charts
Capecitabine, Oxaliplatin, Selenomethionine, and Radiation Therapy in Treating Patients Undergoing Surgery For Newly Diagnosed Stage II or III Rectal Adenocarcinoma
Phase 2 Terminated
5 enrolled 6 charts
STEAM
Phase 2 Terminated
280 enrolled 15 charts
Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Metastatic Colon Cancer
Phase 2 Terminated
10 enrolled 7 charts
Pre- and Post-operative FOLFOX Based Therapy for Patients With Colorectal Cancer With Liver Involvement
Phase 2 Terminated
9 enrolled 12 charts
Study Comparing Pathological Responses Observed on Colorectal Cancer Metastases Resected After Preoperative Treatment Combining Cetuximab With FOLFOX or FOLFIRI in RAS and B-RAF WT Tumors
Phase 2 Terminated
4 enrolled
Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer
Phase 1 Terminated
3 enrolled
BEBYP
Phase 3 Terminated
184 enrolled
Erlotinib and Chemotherapy for 2nd Line Treatment (Tx) of Metastatic Colorectal Cancer (mCRC)
Phase 2 Terminated
16 enrolled 9 charts
IXO+A
Phase 1/2 Terminated
23 enrolled
Oxaliplatin and Capecitabine With or Without an Hepatic Arterial Infusion With Floxuridine in Treating Patients Who Are Undergoing Surgery and/or Ablation for Liver Metastases Due to Colorectal Cancer
Phase 3 Terminated
22 enrolled 3 charts
Combination Chemotherapy Plus Trastuzumab in Treating Patients With Advanced, Recurrent, or Metastatic Colorectal Cancer
Phase 2 Terminated
26 enrolled
FOSCO
Phase 2 Terminated
101 enrolled
VOXEL
Phase 2 Terminated
9 enrolled
Capecitabine, Oxaliplatin, and Gefitinib in Treating Patients With Metastatic Colorectal Cancer
Phase 1/2 Terminated
10 enrolled
Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
Phase 2 Terminated
119 enrolled
Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer
Phase 1 Terminated
12 enrolled
Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer.
Phase 2 Terminated
180 enrolled
CONCEPT: Comparison of Oxaliplatin vs Conventional Methods With Calcium/Magnesium in First-Line Metastatic Colorectal Cancer
Phase 4 Terminated
180 enrolled
Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer
Phase 2 Terminated
40 enrolled
ChronoFOLFOX Plus Avastin for Patients With Metastatic Colorectal Cancer
Phase 2 Terminated
20 enrolled
Tezacitabine and Oxaliplatin for the Treatment of Patients With Metastatic Colorectal Cancer
Phase 2 Terminated
Feasibility Study of mFOLFOX6 in Patients With Advanced Colorectal Cancer
Phase 2 Terminated
30 enrolled